“Clinical and Translational Research in Multiple Myeloma: Novel Immunotherapies, Prognostic Biomarkers and Precision Medicine”

- Participation in the design of prospective and retrospective clinical studies in multiple myeloma.- Clinical data collection and research database management.- Data evaluation of efficacy and safety of novel immunotherapeutic strategies, with particular focus on bispecific antibodies and other innovative immunotherapies.- Correlation between clinical features, treatment response, circulating plasma cells characterization, measurable residual disease (MRD) and clinical outcomes.- Collaboration with the translational research laboratory for integration of biological and clinical data.- Statistical analysis and dissemination of results through scientific publications and presentations at national and international meetings.